Omeprazole and Sodium Bicarbonate
- Product NDC
- 68682-991
- Requested package NDC
- 68682-991-30
- 11-digit product format
- 686820991
- Labeler code
- 68682
- Product ID
- 68682-991_a52d487d-f07a-42f9-998c-c68fa2e1d9c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- omeprazole, sodium bicarbonate
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Oceanside Pharmaceuticals
- Application
- NDA021636
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2004-06-15
- Marketing end
- 0000-00-00
- Substance
- OMEPRAZOLE; SODIUM BICARBONATE
- Active strength
- 40 mg/1; mg/1
- Pharmacologic classes
- Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68682-991 | 68682-991-30 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021636-001 | ZEGERID | OMEPRAZOLE; SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-06-15 | |
| N021636-002 | ZEGERID | OMEPRAZOLE; SODIUM BICARBONATE | 40MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-12-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021636-001 | ZEGERID | 20MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-06-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021636-002 | ZEGERID | 40MG/PACKET;1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SUSPENSION / ORAL | RLD | 2004-12-21 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Bryant Ranch Prepack | 0b1ec3e1-8489-4738-b5c8-9dfa5d8ebb95 | 2025-06-13 | Warnings, Adverse reactions | 021636 NDA021636 |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Oceanside Pharmaceuticals | c26b6893-8264-4d4a-ac7e-1ddda933451e | 2025-05-02 | Warnings, Adverse reactions | 021636 NDA021636 68682-991-30 68682-991 68682099130 |
| ZEGERID | OMEPRAZOLE AND SODIUM BICARBONATE | Santarus, Inc.. | cd6868b9-5824-442b-8d65-4db29ecb70a4 | 2023-07-19 | Warnings, Adverse reactions | 021636 NDA021636 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 873ef493-6b37-49d8-ac7f-bfca4117d2c1 | Product name | 5 | 20210607 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| f33561b9-47cb-411c-a228-16c62e346cd4 | Product name | 1 | 20200415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68682-991-30 | Omeprazole and Sodium Bicarbonate | 30 in 1 CARTON | POWDER, FOR SUSPENSION | 30 | 14 | |
| 68682-991-30 | Omeprazole and Sodium Bicarbonate | 1 in 1 PACKET | POWDER, FOR SUSPENSION | 1 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68682-991 | OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE) POWDER, FOR SUSPENSION OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE) CAPSULE [OCEANSIDE PHARMACEUTICALS] | 14 | Legacy NDC, 2 package rows | 20250504_c26b6893-8264-4d4a-ac7e-1ddda933451e.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 616539 | omeprazole 20 MG / sodium bicarbonate 1100 MG Oral Capsule | PSN | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753562 | omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | PSN | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 616541 | omeprazole 40 MG / sodium bicarbonate 1100 MG Oral Capsule | PSN | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753557 | omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | PSN | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 616539 | omeprazole 20 MG / sodium bicarbonate 1100 MG Oral Capsule | SCD | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753562 | omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | SCD | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 616541 | omeprazole 40 MG / sodium bicarbonate 1100 MG Oral Capsule | SCD | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753557 | omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | SCD | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 616539 | Omeprazole 20 MG / NaHCO3 1100 MG Oral Capsule | SY | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753562 | Omeprazole 20 MG / NaHCO3 1680 MG Powder for Oral Suspension | SY | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 616541 | Omeprazole 40 MG / NaHCO3 1100 MG Oral Capsule | SY | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
| 753557 | Omeprazole 40 MG / NaHCO3 1680 MG Powder for Oral Suspension | SY | c26b6893-8264-4d4a-ac7e-1ddda933451e | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68682-991-30 | 68682099130 | 30 PACKET in 1 CARTON (68682-991-30) > 1 POWDER, FOR SUSPENSION in 1 PACKET | 30 packet | 2004-06-15 | 0000-00-00 | No | No | Current |